Research DepartmentsPeoplePublicationsPostdoc & Student Positions  
 
 Terry Fox Laboratory 
Oliver Christ

Switch to Oliver Christ's research page...

Peer-Reviewed Papers
Peer-Reviewed Papers

    2002

  1. Christ O, Gunthert U, Schmidt DS, Zoller M. Allogeneic reconstitution after nonmyeloablative conditioning: mitigation of graft-versus-host and host-versus-graft reactivity by anti-CD44v6 J Leukoc Biol 71:1 p.33-46 (2002).
     [View Abstract - PubMed 11781378]

  2. 2001

  3. Banat GA, Christ O, Cochlovius B, Pralle HB, Zoller M. Tumour-induced suppression of immune response and its correction. Cancer Immunol Immunother 49(11):573-86. (2001).
     [View Abstract - PubMed 11225988]

  4. Christ O, Gunthert U, Haas R, Zoller M. Importance of CD44v7 isoforms for homing and seeding of hematopoietic progenitor cells. J Leukoc Biol 69(3):343-52. (2001).
     [View Abstract - PubMed 11261780]

  5. Christ O, Kronenwett R, Haas R, Zoller M. Combining G-CSF with a blockade of adhesion strongly improves the reconstitutive capacity of mobilized hematopoietic progenitor cells. Exp Hematol 29(3):380-90. (2001).
     [View Abstract - PubMed 11274767]

  6. Christ O, Matzku S, Burger C, Zoller M. Interleukin 2-antibody and tumor necrosis factor-antibody fusion proteins induce different antitumor immune responses in vivo. Clin Cancer Res 7(5):1385-97. (2001).
     [View Abstract - PubMed 11350910]

  7. Christ O, Seiter S, Matzku S, Burger C, Zoller M. Efficacy of local versus systemic application of antibody-cytokine fusion proteins in tumor therapy. Clin Cancer Res 7(4):985-98. (2001).
     [View Abstract - PubMed 11309350]

  8. Weth R, Christ O, Stevanovic S, Zoller M. Gene delivery by attenuated Salmonella typhimurium: comparing the efficacy of helper versus cytotoxic T cell priming in tumor vaccination. Cancer Gene Ther 8(8):599-611. (2001).
     [View Abstract - PubMed 11571538]

  9. Zoller M, Christ O. Prophylactic tumor vaccination: comparison of effector mechanisms initiated by protein versus DNA vaccination. J Immunol 166(5):3440-50. (2001).
     [View Abstract - PubMed 11207302]

  10. 2000

  11. Cochlovius B, Kipriyanov SM, Stassar MJ, Christ O, Schuhmacher J, Strauss G, Moldenhauer G, Little M. Treatment of human B cell lymphoma xenografts with a CD3 x CD19 diabody and T cells. J Immunol 165(2):888-95. (2000).
     [View Abstract - PubMed 10878363]

  12. Cochlovius B, Stassar M, Christ O, Raddrizzani L, Hammer J, Mytilineos I, Zoller M. In vitro and in vivo induction of a Th cell response toward peptides of the melanoma-associated glycoprotein 100 protein selected by the TEPITOPE program. J Immunol 165(8):4731-41. (2000).
     [View Abstract - PubMed 11035118]


Top of Page Prev (26 of 34) Next

URL: http://www.bccrc.ca/tfl/pubs_ochrist.html
The BC Cancer Agency Research Centre is the research arm of the BC Cancer Agency (BCCA),
and is supported by the BC Cancer Foundation.
This page was last modified at 5:08pm on May 9, 2002
© 1999-2008. BC Cancer Agency. All rights reserved.
About this website...

 
Navigation Menu

View Site Map

Contact Us

BC Cancer Agency Research Centre
675 West 10th Avenue
Vancouver, BC
V5Z 1L3  Canada
1-604-675-8000


We subscribe to the HONcode principles of the Health On the Net Foundation